Skip to main content

CAMT · Camtek Ltd · Metrics

Track CAMT — free
$121.16 +1.68 (+1.41%) At close · Oct 23
Market Cap
$5.65B
Shares
46.67M
Volume · Oct 23 313.74K Avg daily vol (3M) 483.12K

CAMT metrics

60 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$121.16
Market cap
$5.65B

Price action

20 metrics
Price change (1W)
-6.4%
Price change (30D)
-16.5%
Price change (3M)
-18.0%
Price change (6M)
-40.3%
Price change (YTD)
+13.9%
Price change (1Y)
+2.6%
Trailing year
Price change (5Y)
+208.6%
52-week high
$207.46
52-week low
$94.40
Change from 52-week high
-41.6%
Change from 52-week low
+28.3%
Annualized volatility
70.5%
Annualized volatility (3M)
68.7%
Beta
2.8
RSI (14D)
34.0
Price vs SMA 50
-16.1%
Price vs SMA 200
-23.2%
Avg volume (3M)
483,121
Relative volume
0.7
Average dollar volume
$69.97M

Company

3 metrics
Sector
Technology
Industry
Semiconductor Equipment & Materials
Shares outstanding
46.67M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
9.2
reciprocal yield 10.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
50.5%
Operating margin
25.8%
Trailing 12 months
Net margin
10.2%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$13.46

Growth

11 metrics
Revenue growth YoY
+82.3%
Year over year
Net income growth YoY
+194.9%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+169.2%
Shares change YoY
+12.0%
Year over year · more shares
Revenue CAGR (3Y)
+15.6%
Revenue CAGR (5Y)
+26.1%
EPS CAGR (3Y)
-14.8%
EPS CAGR (5Y)
+14.0%
FCF CAGR (3Y)
+37.0%
FCF CAGR (5Y)
+40.4%

Quality

14 metrics
Return on equity
8.2%
Return on assets
4.0%
Debt / equity
—
Current ratio
8.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
7.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$177.85M
Total assets
$1.26B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
240
13F filer change QoQ
+13
Institutional ownership
45.0%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-9.8%
Holder tenure
16.8
Price vs estimated holder cost
+65.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.5%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 11.2 days to cover
Days to cover
11.2d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.10M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1109138 CUSIP M20791105 13F (30d) 20 filings 20 filers Visit website Investor relations